Nav: Home

Surgery is more effective than drug in hyperparathyroidism post-kidney transplantation

December 16, 2015

A study led by researchers from the Nephrology group at Bellvitge Biomedical Research Institute (IDIBELL) and the University Hospital of Bellvitge (HUB), compared the results of surgery with drug therapy in patients with tertiary hyperparathyroidism, ie after a kidney transplant. The results of the research have been published in the journal of greatest impact in the Journal of the American Society of Nephrology.

This is the first clinical trial comparing these two treatments for this disease and has been funded by the Carlos III Health Institute within the call for independent clinical research projects.

Tertiary hyperparathyroidism

50% of patients with a kidney transplant presents tertiary hyperparathyroidism. This complication involves too much calcium, causing cardiovascular worsening by hypercalcemia, bone loss, and worsens the survival of the transplanted organ.

The study was performed in 30 patients. Half of them are operated and the other half have been treated with the usual drug. Researchers have found that surgery totally controls hypercalcemia, normalizes the secretion of parathyroid hormone (PTH) and improves bone density. While treatment only controls excess calcium in 67% of cases, has no effect on PTH and even slows the decline in bone density and does not stop the process.

The principal researcher of the study, Josep Maria Cruzado, explained that "if we have a surgical team with experience in this type of operation, our recommendation in these cases is to operate because it is positive both from the viewpoint of efficiency, since surgery It is a curative treatment, and from the economic point of view: the cost of surgery is equivalent to 14 months of treatment, and the drug must be taken chronically and can not be stopped."

The results of this study could change the clinical practice of tertiary hyperparathyroidism.

Cruzado has also explained that it is a minimally invasive surgery and involves only one day of hospitalization.
-end-
This study was coordinated by Josep M Cruzado, HUB Nephrology and Pablo Moreno of Surgery HUB and also collaborated in this work the nephrology, surgery, rheumatology and radiology services at HUB and further research service nephrology and kidney transplantation at the Clinical Hospital of Barcelona

Referència de l'article

Josep M. Cruzado*, Pablo Moreno†, José V. Torregrosa‡, Omar Taco*, Richard Mast§, Carmen Gómez-Vaquero?, Carolina Polo*, Ignacio Revuelta‡, José Francos†, Joan Torras*, Arantxa García-Barrasa†, Oriol Bestard* and Josep M. Grinyó*. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism. JASN December 8, 2015. doi:10.1681/ASN.2015060622

IDIBELL-Bellvitge Biomedical Research Institute

Related Kidney Transplant Articles:

New blood test can detect rejection by antibodies after kidney transplant
A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies.
Measuring quality of life after pediatric kidney transplant
After receiving a kidney transplant, children may experience worrisome quality-of-life changes that underscore the importance of screening transplant recipients for psychosocial function, according to Children's research presented during the 10th Congress of the International Pediatric Transplant Association.
dnDSA and ethnicity linked with thickening of blood vessels after kidney transplant
Children who developed anti-human leukocyte antibodies against their donor kidney, known as de novo donor-specific antibodies, were more likely to experience carotid intima-media thickening than those without these antibodies, according to preliminary research presented May 7, 2019, during the 10th Congress of the International Pediatric Transplant Association.
Kidney transplant patients need even better aftercare!
Kidney transplantation is the best renal replacement therapy available. Although survival and quality of life are significantly better compared to dialysis patients, transplant recipients nevertheless have a significantly higher cardiovascular morbidity and mortality than healthy people.
Marijuana use has no effect on kidney transplant outcomes
A new study published in Clinical Kidney Journal indicates that the usage of marijuana by kidney donors has no measurable effect upon the outcomes of kidney transplants for donors or recipients.
More Kidney Transplant News and Kidney Transplant Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...